Panel vs. single marker for discriminating desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma

被引:3
|
作者
Vollmer, Robin T. [1 ]
机构
[1] VA Med Ctr, Lab Med 113, Durham, NC USA
关键词
D O I
10.1111/j.1600-0560.2008.01047.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:283 / 283
页数:1
相关论文
共 50 条
  • [1] Panel vs. single marker for discriminating desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma Reply
    Katona, Terrence M.
    Perkins, Susan M.
    Billings, Steven D.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2009, 36 (02) : 284 - 284
  • [2] Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma
    Abbas, Ossama
    Richards, Joanna E.
    Mahalingam, Meera
    MODERN PATHOLOGY, 2010, 23 (11) : 1535 - 1543
  • [3] Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
    Katona, Terrence M.
    Perkins, Susan M.
    Billings, Steven D.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2008, 35 (02) : 174 - 179
  • [4] Morpheaform Basal Cell Carcinoma Masquerading as Desmoplastic Trichoepithelioma in a Young Patient
    Bains, Anupama
    Vishwajeet, Vikarn
    Lahoria, Utkrist
    Bhardwaj, Abhishek
    INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (06)
  • [5] Dermoscopic characteristics of microcystic adnexal carcinoma, desmoplastic trichoepithelioma, and morpheaform basal cell carcinoma
    Costello, Collin M.
    Han, Maggie Y.
    Severson, Kevin J.
    Maly, Connor J.
    Yonan, Yousif
    Nelson, Steven A.
    Swanson, David L.
    Mangold, Aaron R.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (03) : E83 - E84
  • [6] Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma, and Microcystic Adnexal Carcinoma?
    Mohanty, Sambit K.
    Sardana, Ruhani
    McFall, Michael
    Pradhan, Dinesh
    Usmani, Amena
    Jha, Shilpy
    Mishra, Sourav K.
    Sampat, Nakul Y.
    Lobo, Anandi
    Wu, Julie M.
    Balzer, Bonnie L.
    Frishberg, David P.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022, 30 (04) : 273 - 277
  • [7] Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma and Microcystic Adnexal Carcinoma?
    McFall, M. J.
    Mohanty, S. K.
    Usmani, A.
    Wu, J. M.
    Frishberg, D.
    MODERN PATHOLOGY, 2014, 27 : 138A - 138A
  • [8] Does lmmunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepitheiioma, Morpheaform Basal Cell Carcinoma and Microcystic Adnexal Carcinoma?
    McFall, M. J.
    Mohanty, S. K.
    Usmani, A.
    Wu, J. M.
    Frishberg, D.
    LABORATORY INVESTIGATION, 2014, 94 : 138A - 138A
  • [9] Androgen receptor and cytokeratin 20 immunohistochemical stains can differentiate morpheaform basal cell carcinoma from desmoplastic trichoepithelioma
    Katona, T. M.
    Perkins, S. M.
    Billings, S. D.
    LABORATORY INVESTIGATION, 2007, 87 : 95A - 95A
  • [10] The utility of immunohistochemistry in differentiating desmoplastic trichoepithelioma from basal cell carcinoma
    De'Ambrosis, S.
    Gluch, J.
    O'Brien, B.
    Blake, T.
    Blake, T.
    King, J.
    De'Ambrosis, B.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 47 - 47